VocaVibe is set to become the preferred choice for Parkinson's disease (PD) management by offering non-invasive, AI-driven diagnostics through vocal biomarkers. This technology provides early and accurate diagnosis, enabling continuous and real-time monitoring of disease progression and treatment efficacy. By improving patient management and allowing for effortless remote assessments, VocaVibe significantly enhances patient quality of life. It also reduces healthcare costs by minimizing hospital visits and preventing complications through timely interventions. Our strategic partnerships and proven clinical results further establish VocaVibe as the future standard of care in PD management.
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 18 classification IDs that could be used for matching.
VocaVibe Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
Confidence
71/100
Missing
sector, tags, video or image, news, markets, external profiles, not claimed
BI Verification
Matan Eblagon
Registrar ID
516679184
Creator
Ariel Shiff
Creator email
ariel@vocavibe.ai
Last updater
Matan Eblagon
Updater email
matane@sncentral.org
Last update
2024-07-14T00:00:00.000Z
Created
2024-07-11T00:00:00.000Z
Claimed
Yes
Generate Slim Page
We use cookies and Google Analytics to understand how visitors use this site. Help improve it by accepting?
